IP40

Research IP40 on Bullrun: market cap EUR 6.70M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIP40
• ExchangeF
• CountryCanada
• SectorConsumer Defensive
• IndustryHousehold & Personal Products
• CurrencyEUR
• Market capEUR 6.70M
• Financial periodQ4 2025
• RevenueEUR 4.99M
• Net incomeEUR 2.00M
• Free cash flow-EUR 587.00K
• Gross margin88.8%

Valuation Snapshot

latest market cap is EUR 6.70M.

About IP40

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors.

Frequently asked questions

What is IP40's market cap?

IP40's market capitalization is EUR 6.70M.

What does IP40 do?

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations.